HUTCHMED (China) Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HMDCF research report →
About the company
HUTCHMED (China) Ltd. operates as a holding company, specializing in the research, development, manufacturing, and sales of both pharmaceutical products and health-focused consumer goods. The company's operations are divided into two main segments: Oncology/Immunology and Other Ventures.
- CEO
- Chig Fung Cheng
- IPO
- 2014
- Employees
- 1,811
- HQ
- Hong Kong, HK
Price Chart
- Market Cap
- $1.86B
- P/E
- 50.76
- P/S
- 3.61
- P/B
- 18.74
- EV/EBITDA
- -77.57
- Div Yield
- 0.00%
- Gross Margin
- 11.64%
- Op Margin
- -7.14%
- Net Margin
- 83.30%
- ROE
- 37.04%
- ROIC
- -2.35%
- Revenue
- $549.32M · -12.83%
- Net Income
- $457.58M · 1112.82%
- EPS
- $0.53 · 1101.81%
- Op Income
- $-54,661,741
- FCF YoY
- -352.64%
- 52W High
- $3.81
- 52W Low
- $2.16
- 50D MA
- $2.40
- 200D MA
- $3.06
- Beta
- 0.43
- Avg Volume
- 2
Get TickerSpark's AI analysis on HMDCF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our HMDCF coverage
Recent articles, reports, and earnings notes.
No research on HMDCF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate HMDCF report →Similar companies
Peers in the same neighborhood.